SF3B6 and cancer: Our results demonstrated that SF3B6 expression was positively related to many immune checkpoint molecules in six types of cancer, including LIHC, while demonstrating a negative correlation with most immune checkpoint molecules in seven additional cancers, including LUAD and HNSC.